Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$4.35 - $8.79 $585,075 - $1.18 Million
-134,500 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$4.23 - $8.29 $568,935 - $1.12 Million
134,500 New
134,500 $1.01 Million
Q3 2018

Nov 13, 2018

SELL
$3.75 - $4.65 $1.43 Million - $1.77 Million
-380,000 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$3.7 - $5.8 $1.41 Million - $2.2 Million
380,000 New
380,000 $1.41 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $787M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.